November 2023
1. TAYLOR-COUSAR JL, Boyd AC, Alton EWFW, Polineni D, et al
   Genetic therapies in cystic fibrosis.
   Curr Opin Pulm Med. 2023;29:615-620.
   

   >> Share

   
   
2. NARKEWICZ MR
   Cystic fibrosis liver disease in the post-modulator era.
   Curr Opin Pulm Med. 2023;29:621-625.
   

   >> Share

   
   
3. WAJDA KE, Roesch EA, Gifford AH
   Chronic daily respiratory care needs in people with cystic fibrosis treated with highly effective cystic fibrosis transmembrane conductance regulator modulators.
   Curr Opin Pulm Med. 2023;29:580-586.
   

   >> Share

   
   
4. JAIN R, Kazmerski TM, Taylor-Cousar JL
   The modern landscape of fertility, pregnancy, and parenthood in people with cystic fibrosis.
   Curr Opin Pulm Med. 2023;29:595-602.
   

   >> Share

   
   July 2023
5. EDMONDSON C, Lechtzin N
   Telemedicine and remote monitoring in cystic fibrosis.
   Curr Opin Pulm Med. 2023;29:277-284.
   

   >> Share

   
   November 2022
6. WILSCHANSKI M, Peckham D
   Nutritional and metabolic management for cystic fibrosis in a post-cystic fibrosis transmembrane conductance modulator era.
   Curr Opin Pulm Med. 2022;28:577-583.
   

   >> Share

   
   
7. JONES AM
   Infection control in cystic fibrosis: evolving perspectives and challenges.
   Curr Opin Pulm Med. 2022;28:571-576.
   

   >> Share

   
   
8. HONG G
   Progress and challenges in fungal lung disease in cystic fibrosis.
   Curr Opin Pulm Med. 2022;28:584-590.
   

   >> Share

   
   November 2021
9. BURGEL PR, Goss C
   COVID-19 outcomes in people with cystic fibrosis.
   Curr Opin Pulm Med. 2021;27:538-543.
   

   >> Share

   
   
10. VAGG T, Shanthikumar S, Morrissy D, Chapman WW, et al
    Telehealth and virtual health monitoring in cystic fibrosis.
    Curr Opin Pulm Med. 2021;27:544-553.
    

    >> Share

    
    
11. FAJAC I, Sermet-Gaudelus I
    Therapeutic pipeline for individuals with cystic fibrosis with mutations nonresponsive to current cystic fibrosis transmembrane conductance regulator modulators.
    Curr Opin Pulm Med. 2021;27:567-574.
    

    >> Share

    
    
12. ATHWAL VS, Scott JA, Fitzpatrick E, Rowland M, et al
    Emerging clinical perspectives in cystic fibrosis liver disease.
    Curr Opin Pulm Med. 2021;27:593-599.
    

    >> Share

    
    
13. CROWLEY C, Connor OJO, Ciet P, Tiddens HAWM, et al
    The evolving role of radiological imaging in cystic fibrosis.
    Curr Opin Pulm Med. 2021;27:575-585.
    

    >> Share

    
    
14. BARRY PJ, Plant BJ
    Editorial: A future focus on cystic fibrosis in an era of uncertainty despite opportunity.
    Curr Opin Pulm Med. 2021;27:535-537.
    

    >> Share

    
    
15. NICK JA, Daley CL, Lenhart-Pendergrass PM, Davidson RM, et al
    Nontuberculous mycobacteria in cystic fibrosis.
    Curr Opin Pulm Med. 2021;27:586-592.
    

    >> Share

    
    
16. BARRY PJ, Taylor-Cousar JL
    Triple combination cystic fibrosis transmembrane conductance regulator modulator therapy in the real world - opportunities and challenges.
    Curr Opin Pulm Med. 2021;27:554-566.
    

    >> Share

    
    March 2021
17. MUTHU V, Prasad KT, Sehgal IS, Dhooria S, et al
    Obstructive lung diseases and allergic bronchopulmonary aspergillosis.
    Curr Opin Pulm Med. 2021;27:105-112.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share